Biotech Firm's Mammoth Revival Plans Spark Debate
A Texas biotech company is working to revive extinct mammoths, raising intriguing scientific prospects and thorny ethical questions.
Colossal Biosciences, a Texas-based biotech firm, is making waves with its ambitious plans to bring mammoths and other extinct creatures back to life. The company's de-extinction efforts are as scientifically intriguing as they are ethically thorny, sparking intense debates within the scientific community and beyond.
At the heart of Colossal's work is the goal of resurrecting the woolly mammoth, a majestic Ice Age behemoth that went extinct around 10,000 years ago. The company's co-founder and chief scientific officer, Beth Shapiro, a renowned evolutionary biologist, believes that by leveraging advances in genetic engineering and cloning technologies, they can recover and sequence the mammoth's DNA, then use that information to edit the genome of its closest living relative, the Asian elephant.
Source: NPR
